Non-hallucinogenic cannabinoids are effective anti-cancer drugs
The anti-cancer properties of tetrahydrocannabinol (THC), the primary hallucinogenic component of cannabis, has been recognised for many years, but research into similar cannabis-derived compounds, known as cannabinoids, has been limited. The study was carried out by a team at St George’s, University of London. It has been published in the journal Anticancer Research. …